Picture EBD Group Biotech Showcase 2023 San Francisco 650x100px

News > All

Total search results: 6715 | Ordered by Date (descending)
1 2 3 ... 66 67 68  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
MedinCell S.A.. (11/30/22). "Press Release: Additional US$ 4 Million Received for Next Development Steps of MedinCell’s 6-month Active Injectable Bioresorbable Subcutaneous Contraceptive". Montpellier. 2022-11-30
Intellia Therapeutics, Inc.. (11/30/22). "Press Release: Intellia Therapeutics Announces Proposed Public Offering of Common Stock". Cambridge, MA. 2022-11-30
Intellia Therapeutics, Inc.. (11/30/22). "Press Release: Intellia Therapeutics Announces Pricing of Public Offering of Common Stock". Cambridge, MA. 2022-11-30
Envisagenics, Inc.. (11/29/22). "Press Release: Envisagenics Announces Research Collaboration with Bristol Myers Squibb". New York, NY. 2022-11-29
Touchlight Genetics Ltd.. (11/29/22). "Press Release: Touchlight Receives Grant to Advance Rapid, Scalable and Thermostable doggybone DNA Vaccine Platform". Hampton. 2022-11-29
AstraZeneca plc. (11/29/22). "Press Release: AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy". 2022-11-29
Full-Life Technologies Ltd.. (11/29/22). "Press Release: Full-Life Technologies to Acquire Focus-X Therapeutics, Bolstering Peptide-focused Radiopharmaceutical Pipeline". Brussels, Watchung, NJ & Shanghai. 2022-11-29
Strand Therapeutics Inc.. (11/28/22). "Press Release: Strand Therapeutics Announces Series A1 Bringing Total Round to US$97 Million". Boston, MA. 2022-11-28
V7 Ltd.. (11/28/22). "Press Release: V7 Raises a $33m Series A to Help Teams Build Robust AI, Faster". London. 2022-11-28
Fujifilm Corporation. (11/22/22). "Press Release: Fujifilm Invests $188 Million in New Cell Culture Media Manufacturing Facility". Tokyo. 2022-11-22
G1 Therapeutics, Inc.. (11/22/22). "Press Release: G1 Therapeutics Announces Closing of Offering of Common Stock". Research Triangle Park, NC. 2022-11-22
Uniqure N.V.. (11/22/22). "Press Release: Uniqure Announces FDA Approval of First Gene Therapy for Adults with Hemophilia B". Research Triangle Park, NC. 2022-11-22
Turbine Simulated Cell Technologies Ltd.. (11/22/22). "Press Release: Turbine Raises €20 Million in Series A Financing to Advance Programs & Partnerships Towards the Clinic with World’s First Cancer Cell Simulation Platform". London & Budapest. 2022-11-22
Catalym GmbH. (11/22/22). "Press Release: Catalym Closes EUR 50 Million Series C Financing to Expand and Accelerate Phase 2 Clinical Development of Visugromab in Patients with Solid Tumors". Oxford. 2022-11-22
Oxford Biomedica plc. (11/22/22). "Press Release: Oxford Biomedica Appoints Dr Frank Mathias as Chief Executive Officer". Oxford. 2022-11-22
Xlife Sciences AG. (11/21/22). "Press Release: Xlife Sciences Initiates a Review of Strategic Options". Zürich. 2022-11-21
Merck & Co., Inc.. (11/21/22). "Press Release: Merck to Acquire Imago BioSciences, Inc. – Acquisition Expands Merck’s Growing Hematology Portfolio". Rahway, NJ & South San Francisco, CA. 2022-11-21
Cambrex Corporation. (11/21/22). "Press Release: Cambrex to Acquire Snapdragon Chemistry, a Leader in Continuous Flow API Development Services". East Rutherford, NJ. 2022-11-21
FogPharma (Fog Pharmaceuticals Inc.). (11/21/22). "Press Release: FogPharma Announces $178 Million Series D Financing to Advance Pipeline of First-in-Class Helicon Polypeptide Therapeutics Targeting Major Cancer Drivers". Cambridge, MA. 2022-11-21
Cradle Bio B.V.. (11/17/22). "Press Release: Biotech Startup Cradle Exits Stealth, Raises $5.5M to Design Protein-machines and Cell-factories with AI". 2022-11-17
Valneva S.E.. (11/17/22). "Press Release: Valneva Appoints Dipal Patel as Chief Commercial Officer". Saint-Herblain. 2022-11-17
Kriya Therapeutics, Inc.. (11/16/22). "Press Release: Kriya Acquires Redpin Therapeutics, Adding Neurology Pipeline to Gene Therapy Portfolio". Redwood City, CA & Research Triangle Park, NC. 2022-11-16
Rentschler Biopharma SE. (11/16/22). "Press Release: Rentschler Biopharma Appoints Christiane Bardroff as Chief Operating Officer and Member of the Executive Board". Laupheim. 2022-11-16
Jnana Therapeutics Inc.. (11/15/22). "Press Release: Jnana Therapeutics Raises $107 Million to Advance Lead PKU Program and Progress Therapeutics Pipeline Discovered by the RAPID Platform". Boston, MA. 2022-11-15
Touchlight Genetics Ltd.. (11/15/22). "Press Release: Touchlight Signs License Agreement with Voyager for Use of Touchlight’s DNA Technology in Voyager’s Capsid Discovery Platform". Hampton. 2022-11-15
Jnana Therapeutics Inc.. (11/15/22). "Press Release: Jnana Therapeutics Announces Second Collaboration with Roche to Address Challenging-to-Drug Targets in Cancer, Immune-Mediated and Neurological Diseases". Boston, MA. 2022-11-15
Bruker Corporation. (11/14/22). "Press Release: Bruker Announces Agreement to Acquire Neurescence Inc., Bolstering Neuroscience Research Portfolio". Billerica, MA. 2022-11-14
Bayer AG. (11/10/22). "Press Release: Bayer Acquires German Biotech Start-up Targenomix". Monheim. 2022-11-10
NRG Therapeutics Ltd.. (11/9/22). "Press Release: NRG Therapeutics Announces £16 Million Series A to Advance Mitochondrial Therapeutics for Parkinson’s and ALS". Stevenage. 2022-11-09
Selvita S.A.. (11/9/22). "Press Release: Selvita Group Reports Strong Business Performance for Q3 YTD 2022". Kraków. 2022-11-09
Insilico Medicine. (11/8/22). "Press Release: Insilico Medicine Signs Strategic Research Collaboration with Sanofi Worth up to $1.2 Billion". New York, NY. 2022-11-08
BC Platforms AG. (11/8/22). "Press Release: BC Platforms Announces USD 20 Million Growth Financing Led by Jolt Capital". 2022-11-08
Azenta, Inc.. (11/8/22). "Press Release: Azenta and the Government of Luxembourg Announce a Memorandum of Understanding to Facilitate Continued Healthcare Technology Development in Luxembourg". Chelmsford, MA. 2022-11-08
VectorY B.V.. (11/8/22). "Press Release: VectorY Appoints Sander van Deventer as CEO and Makes Key Appointments to Its Leadership Team". Amsterdam. 2022-11-08
Adaptimmune Therapeutics plc. (11/8/22). "Press Release: Adaptimmune Reports Third-Quarter Financial Results and Business Update". Philadelphia, PA & Oxford. 2022-11-08
Bruker Corporation. (11/8/22). "Press Release: Bruker Announces Acquisition of Inscopix for Neuroscience Research". Mountain View, CA. 2022-11-08
Bruker Corporation. (11/7/22). "Press Release: Bruker Corporation to Participate in the 2022 Jefferies London Healthcare Conference". Billerica, MA. 2022-11-07
OxSonics Therapeutics Ltd.. (11/7/22). "Press Release: Jérôme Marzinski Appointed as Chief Executive Officer". Oxford. 2022-11-07
Novadip Biosciences S.A.. (11/3/22). "Press Release: Novadip Biosciences Raises Additional EUR 40 Million Bringing Total Company Funding to EUR 88 Million". Mont-Saint-Guibert. 2022-11-03
Affimed N.V.. (11/3/22). "Press Release: Affimed and Artiva Biotherapeutics Announce Partnership to Advance Combination Therapy of Innate Cell Engager (ICE) AFM13 and Off-the-Shelf Allogeneic NK Cell Therapy AB-101". Heidelberg & San Diego, CA. 2022-11-03
Centogene N.V.. (11/3/22). "Press Release: Centogene Launches Rare and Neurodegenerative Disease Biodata Network". Cambridge, MA, Rostock & Berlin. 2022-11-03
Werfen. (11/3/22). "Press Release: Werfen to Acquire Immucor, Inc., Expanding Its Presence in Specialized DiagnosticsNeurological Disorders". Barcelona. 2022-11-03
Bayer AG. (11/3/22). "Press Release: Leaps by Bayer Leads Investment Round in AgTech Pioneer NuCicer to Bring Unique and Cost-effective Plant-protein Ingredients to Market by 2023". Davis, CA & Leverkusen. 2022-11-03
Exscientia plc. (11/3/22). "Press Release: Exscientia Expands Biologics Design Capability with Automated Laboratory". Oxford. 2022-11-03
Lusaris Therapeutics, Inc.. (11/2/22). "Press Release: Lusaris Therapeutics Launches with $60 Million Series A Financing to Redefine the Treatment of Severe Neuropsychiatric and Neurological Disorders". Boston, MA. 2022-11-02
Enzyre B.V.. (11/2/22). "Press Release: Enzyre Closes Series A Financing Round of EUR 12M to Advance Pioneering Diagnostic Technology Platform for Hemophilia Patients". Nijmegen. 2022-11-02
ADC Therapeutics S.A.. (11/1/22). "Press Release: ADC Therapeutics Appoints Kristen Harrington-Smith as Chief Commercial Officer and Peter Graham as Chief Legal Officer". Lausanne. 2022-11-01
Exscientia plc. (11/1/22). "Press Release: Exscientia to Present at Upcoming Investor Conferences in November". Oxford. 2022-11-01
Affimed N.V.. (11/1/22). "Press Release: Affimed to Present at the 2022 Jefferies London Healthcare Conference". Heidelberg. 2022-11-01
Thermo Fisher Scientific Inc.. (10/31/22). "Press Release: Thermo Fisher Scientific to Acquire The Binding Site Group". Waltham, MA. 2022-10-31
PhoreMost Ltd.. (10/28/22). "Press Release: PhoreMost Enters Multi-target Collaboration with Targeted Protein Degradation Leader Arvinas". Cambridge. 2022-10-28
Medicines Discovery Catapult (MDC). (10/26/22). "Press Release: Medicines Discovery Catapult Appoints International Entrepreneur Volker Hirsch to Bolster Commercial Expertise". 2022-10-26
Kizoo Technology Capital GmbH. (10/26/22). "Press Release: Kizoo Invests in Rejuvenation Startup MoglingBio". Berlin & Ulm. 2022-10-26
Alto Neuroscience Inc.. (10/25/22). "Press Release: Alto Neuroscience Announces $35 Million Series B Financing". Los Altos, CA. 2022-10-25
Resolve Biosciences GmbH. (10/25/22). "Press Release: Resolve Biosciences Appoints Chief Commercial Officer to Drive Worldwide Adoption of Molecular Cartography Workflow". Monheim. 2022-10-25
Normunity, Inc.. (10/25/22). "Press Release: Normunity Announces $65 Million Series A Financing to Expand the Frontier of Precision Immuno-oncology with Immune Normalizer Therapies". Boston, MA & West Haven, CT. 2022-10-25
Adaptimmune Therapeutics plc. (10/25/22). "Press Release: Adaptimmune Enhances Its Pipeline of Wholly Owned Cell Therapies for Cancer with Transfer of PRAME and NY-ESO Target Programs from GSK". Philadelphia, PA & Oxford. 2022-10-25
Resolve Biosciences GmbH. (10/24/22). "Press Release: Resolve Biosciences Secures $71 Million Series B Financing to Accelerate Commercial Expansion to Meet Global Demand for Molecular Cartography Workflow". Monheim. 2022-10-24
AbbVie Inc.. (10/20/22). "Press Release: AbbVie Acquires DJS Antibodies, Further Strengthening Immunology Pipeline". North Chicago, IL. 2022-10-20
Hookipa Pharma Inc.. (10/20/22). "Press Release: Hookipa Announces Strategic Collaboration and License Agreement with Roche to Develop Novel Arenaviral Immunotherapy for KRAS-mutated Cancers". New York, NY & Vienna. 2022-10-20
Nucleome Therapeutics Ltd.. (10/19/22). "Press Release: Nucleome Therapeutics Raises oversubscribed £37.5 Million Series A Financing to Decode the Dark Matter of the Human Genome and Deliver First-in-Class Precision Medicines". Oxford. 2022-10-19
Univercells S.A.. (10/19/22). "Press Release: Univercells Raises € 44 Million in First Close of Its Series D". Brussels. 2022-10-19
Prime Medicine, Inc.. (10/19/22). "Press Release: Prime Medicine Announces Pricing of Upsized Initial Public Offering". Cambridge, MA. 2022-10-19
Orionis Biosciences. (10/19/22). "Press Release: Orionis Biosciences Secures $55 Million Financing to Support Advancement into Clinic". Boston, MA & Ghent. 2022-10-19
Empyrean Neuroscience, Inc.. (10/18/22). "Press Release: Empyrean Neuroscience Launches with $22M Series A and Genetic Engineering Platform to Advance Pipeline of Neuroactive Compounds Targeting CNS Disorders". New York, NY & Cambridge. 2022-10-18
GSK plc. (10/18/22). "Press Release: GSK Announces Expanded Collaboration with Tempus in Precision Medicine to Accelerate R&D". London. 2022-10-18
Anokion S.A.. (10/18/22). "Press Release: Anokion Announces $35 Million Equity Investment from Pfizer". Cambridge, MA & Lausanne. 2022-10-18
PBD Biotech Ltd.. (10/17/22). "Press Release: PBD Biotech Raises further £2.4m for Its Breakthrough Tuberculosis Blood Test". 2022-10-17
Co.don AG. (10/17/22). "Pressemitteilung: Vereinbarung über die Veräußerung des Geschäftsbetriebs". Teltow & Leipzig. 2022-10-17
Matchpoint Therapeutics, Inc.. (10/14/22). "Press Release: Matchpoint Therapeutics Launches with $100 Million to Deliver on the Promise of Precision Covalent Medicines for Immune Diseases". Cambridge, MA. 2022-10-14
Illumina, Inc.. (10/11/22). "Press Release: Illumina Launches Strategic Research Collaboration with AstraZeneca to Accelerate Drug Target Discovery". San Diego, CA. 2022-10-11
Apollo Health Ventures. (10/11/22). "Press Release: Apollo Health Ventures and Paul Scherrer Institute Launch Focal Biosciences". Boston, MA, Berlin & Villigen. 2022-10-11
Andera Partners. (10/10/22). "Press Release: Andera Partners Raises Its Largest Life Sciences Fund at €456M, Demonstrating the Attractiveness of Its Activity and of the Sector". Paris. 2022-10-10
Immatics N.V.. (10/10/22). "Press Release: Immatics Reports Interim Clinical Data Update on ACTengine IMA203 TCR-T Monotherapy Targeting PRAME". Houston, TX & Tübingen. 2022-10-10
Immatics N.V.. (10/10/22). "Press Release: Immatics Announces $110 Million Underwritten Offering of Ordinary Shares". Houston, TX & Tübingen. 2022-10-10
T-Curx GmbH. (10/6/22). "Press Release: T-Curx GmbH, a German CAR-T Cell Biotech Spin-Off from University of Würzburg, Appoints Ulf Grawunder as CEO". Würzburg. 2022-10-06
Cytiva. (10/6/22). "Press Release: Cytiva Strengthens Cell Line Development with Cevec Acquisition". 2022-10-06
Cellarity Inc.. (10/4/22). "Press Release: Cellarity Announces Close of $121 Million Series C Financing". Somerville, MA. 2022-10-04
Valneva S.E.. (10/4/22). "Press Release: Valneva Announces Closing of Upsized €102.9 Million Global Offering". Saint-Herblain. 2022-10-04
Owkin. (10/4/22). "Press Release: Owkin Appoints Sanofi’s Global Head of Partnering Alban de La Sablière as Chief Business Officer". 2022-10-04
LogicBio Therapeutics, Inc.. (10/3/22). "Press Release: Alexion, AstraZeneca Rare Disease to Acquire LogicBio Therapeutics to Accelerate Growth in Genomic Medicine". Lexington, MA. 2022-10-03
Azenta, Inc.. (10/3/22). "Press Release: Azenta Announces Completion of B Medical Systems Acquisition". Chelmsford, MA. 2022-10-03
EnPlusOne Biosciences, Inc.. (9/30/22). "Press Release: EnPlusOne Biosciences Launches Enzymatic RNA Synthesis Platform with $12 Million in Seed Financing". Watertown, MA. 2022-09-30
Xund Solutions GmbH. (9/29/22). "Press Release: Healthtech Start-up Xund Raises €6m – One of the Largest Seed Rounds to Date in Austria". 2022-09-29
Ventus Therapeutics, Inc.. (9/29/22). "Press Release: Ventus Therapeutics Enters Exclusive Development and License Agreement with Novo Nordisk for NLRP3 Inhibitor Program". Waltham, MA & Montréal, QC. 2022-09-29
Pheon Therapeutics Ltd.. (9/28/22). "Press Release: Pheon Therapeutics Launches with $68 Million in Financing to Advance Novel Antibody-Drug Conjugates for Treatment of Solid Tumors". London. 2022-09-28
Kupando GmbH. (9/26/22). "Press Release: Kupando Raises €13 Million in Series A Funding Round". Schönefeld. 2022-09-26
Navigo Proteins GmbH. (9/26/22). "Press Release: Navigo and Mannin Sign Agreement to Develop Innovative Affinity Ligand Against a Novel Drug for the Treatment of COVID-19". Halle (Saale). 2022-09-26
GSK plc. (9/22/22). "Press Release: GSK and Spero Therapeutics Announce Exclusive Licence Agreement for tebipenem HBr, a Late-stage Antibiotic that May Treat Complicated Urinary Tract Infections". London. 2022-09-22
Merck KGaA. (9/21/22). "Press Release: Merck Opens New € 29 Million Biologics Testing Center in Shanghai". Shanghai. 2022-09-21
Novo Nordisk Foundation. (9/21/22). "Press Release: Major Investment for Developing Denmark’s First Fully Functional Quantum Computer". 2022-09-21
Hedera Dx S.A.. (9/21/22). "Press Release: Hedera Dx Raises €14 Million in Seed Funding to Accelerate Global Adoption of Liquid Biopsies". Lausanne. 2022-09-21
Adapsyn Bioscience Inc.. (9/21/22). "Press Release: Adapsyn Bioscience Enters into Strategic Collaboration with Evotec". Hamilton, ON. 2022-09-21
Scitara Corporation. (9/20/22). "Press Release: Scitara Announces Partnership with Agilent to Benefit Customers with Enhanced Digital Lab Connectivity". Marlborough, MA. 2022-09-20
CytoReason Ltd.. (9/20/22). "Press Release: CytoReason Announces Expanded Collaboration Deal with Pfizer to Deliver AI for Drug Discovery and Development". Tel Aviv. 2022-09-20
Evotec SE. (9/20/22). "Press Release: Just – Evotec Biologics Awarded Contract from the U.S. Department of Defense under Accelerated Antibodies Program". Hamburg. 2022-09-20
Nuvisan ICB GmbH. (9/20/22). "Press Release: Nuvisan Receives US$ 9.6m Grant for a Multi-target Drug Discovery Program on Novel Non-hormonal Contraceptive Medicines". Berlin. 2022-09-20
Onego Bio Ltd.. (9/20/22). "Press Release: Perfect Day Deepens Investment in Enterprise Biology Business with New Brand Identity, nth Bio, and Announces Partnership with Onego Bio". Salt Lake City, UT. 2022-09-20
Genfit S.A.. (9/19/22). "Press Release: Genfit to Acquire Clinical-stage Biopharmaceutical Company Versantis, Expanding Its Portfolio in Liver Diseases". Lille & Cambridge, MA. 2022-09-19
Scailyte AG. (9/19/22). "Press Release: Scailyte Closes Series A Funding with a CHF 6 Million Investment". 2022-09-19
1 2 3 ... 66 67 68  next pagenext page


Picture Wirtschaftsförderung Sachsen Life Sciences in Saxony 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Campus Berlin-Buch GmbH CBB Location of Future Innovation 650x300px

» top